— Know what they know.
Not Investment Advice

ADGM

Adagio Medical Holdings, Inc.
1W: +5.7% 1M: +12.0% 3M: -8.3% YTD: +2.8% 1Y: +22.9%
$1.13
+0.10 (+9.71%)
 
NASDAQ · Healthcare · Medical - Devices · $17.2M · Alpha Radar Buy · Power 54
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$17.2M
52W Range0.625-2.87
Volume112,832
Avg Volume90,774
Beta0.14
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOTodd Usen
Employees80
SectorHealthcare
IndustryMedical - Devices
IPO Date2024-07-23
26051 Merit Circle
Laguna Hills, DE 92653
US
949-348-1188
About Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Recent Insider Trades

NameTypeSharesPriceDate
Kaster Deborah A-Award 490,500 $0.98 2026-03-06
Usen Todd A-Award 800,000 $0.98 2026-03-06
Kaster Deborah P-Purchase 15,000 $1.20 2025-12-16
Usen Todd P-Purchase 207,315 $1.09 2025-12-12
Salmon Sean A-Award 90,000 $0.88 2025-12-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms